Brief: Sagimet Biosciences Announces Closing Of Underwriters’ Option To Purchase Additional Shares Of Series A Common Stock In Connection With Its Upsized Initial Public Offering
15/08/2023 21:11
Sagimet Biosciences Inc SGMT.O :
* SAGIMET BIOSCIENCES ANNOUNCES CLOSING OF UNDERWRITERS’
OPTION TO
PURCHASE ADDITIONAL SHARES OF SERIES A COMMON STOCK IN
CONNECTION WITH ITS UPSIZED INITIAL PUBLIC OFFERING
Source text for Eikon: ID:nGNXWW4zF
Further company coverage: SGMT.O
Recent news on Sagimet Biosciences
See all newsBrief: Sagimet Biosciences Announces Pricing Of $115.0 Million Underwritten Offering Of Series A Common Stock And Pre-Funded Warrants
Brief: Sagimet Biosciences - Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30
Brief: Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial Of Denifanstat In Acne Toward Patient Enrollment In Q4 2026
Brief: Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage